PDA cannot support DiCE best practice guidance
We are unable to recommend reliance upon guidance published by the Digital Clinical Excellence (DiCE) for online prescribing of GLP-1 receptor agonists for weight management in adults as it conflicts with an expert report commissioned by the General Pharmaceutical Council (GPhC).
The report is currently being used to prosecute significant numbers of pharmacist prescribers who use a questionnaire-based model of consultation.
We are calling upon the GPhC to issue unambiguous guidance about its expectations as, at the moment, pharmacists prescribing GLP1-RA medication based upon an asynchronous model expose themselves to the risk of possible regulatory action. |